Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen(University of Colorado Anschutz Medical Campus), Richard J. Johnson(University of Colorado Anschutz Medical Campus), Kristen J. Nadeau(Children's Hospital Colorado), Manal F. Abdelmalek(Mayo Clinic), Hugo R. Rosen(University of Colorado Anschutz Medical Campus), Anna Mae Diehl(Duke Medical Center), Dean R. Tolan(Boston University), Carmen Roncal(University of Colorado Anschutz Medical Campus), Masanari Kuwabara(Jichi Medical University), Yuka Sato(University of Colorado Anschutz Medical Campus), Miguel A. Lanaspa(University of Colorado Anschutz Medical Campus), Takahiko Nakagawa(Shiga University), Laura Gabriela Sánchez‐Lozada(Instituto Nacional de Cardiología), Shelby Sullivan(University of Colorado Anschutz Medical Campus), Melanie Cree‐Green(University of Colorado Boulder), Duk‐Hee Kang(Ewha Womans University Medical Center)
Cited by 938
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k